Renaissancere Holdings Ltd. Purchases New Shares in Trupanion, Inc. $TRUP

Renaissancere Holdings Ltd. bought a new stake in Trupanion, Inc. (NASDAQ:TRUP) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 263,000 shares of the financial services provider’s stock, valued at approximately $6,514,510,000. Trupanion makes up approximately 1.5% of Renaissancere Holdings Ltd.’s holdings, making the stock its 5th biggest holding.

A number of other institutional investors have also made changes to their positions in the business. BlackRock Inc. bought a new position in Trupanion in the 2nd quarter worth approximately $134,774,000. Deutsche Bank AG acquired a new position in Trupanion during the 2nd quarter worth $1,839,000. Bank of New York Mellon Corp bought a new position in Trupanion in the 2nd quarter valued at $4,631,000. State of Wyoming bought a new position in Trupanion in the 2nd quarter valued at $452,000. Finally, Kelleher Financial Advisors acquired a new stake in shares of Trupanion in the 2nd quarter valued at $42,000.

Insiders Place Their Bets

In other news, CFO Fawwad Qureshi sold 6,177 shares of Trupanion stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total transaction of $137,005.86. Following the transaction, the chief financial officer owned 2,081 shares in the company, valued at $46,156.58. The trade was a 74.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the completion of the transaction, the executive vice president owned 78,062 shares of the company’s stock, valued at $1,717,364. This represents a 7.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 18,785 shares of company stock worth $422,862. 5.58% of the stock is owned by company insiders.

Trupanion Price Performance

Shares of TRUP stock opened at $29.99 on Tuesday. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $49.26. The stock has a market cap of $1.32 billion, a PE ratio of 56.59, a PEG ratio of 2.20 and a beta of 1.39. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The firm’s 50 day moving average price is $25.72 and its two-hundred day moving average price is $26.05.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The business had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.22 earnings per share. As a group, analysts forecast that Trupanion, Inc. will post 0.59 EPS for the current year.

Analysts Set New Price Targets

TRUP has been the subject of a number of recent research reports. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, August 12th. Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Stifel Nicolaus set a $28.00 price objective on Trupanion in a research report on Friday, June 26th. Finally, Atlantic Securities set a $42.00 price objective on Trupanion in a report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $41.60.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.